India Globalization Capital Inc
Change company Symbol lookup
Select an option...
IGC India Globalization Capital Inc
ZH Zhihu Inc
BWXT BWX Technologies Inc
HYZNW Hyzon Motors Equity Warrants Exp 2nd Oct 2025 *W EXP 10/02/2025
HBNC Horizon Bancorp Inc
WYNMY Wynn Macau Ltd
BOAS BOA Acquisition Corp
NKTR Nektar Therapeutics
BB BlackBerry Ltd
DXCM Dexcom Inc

Industrials : Trading Companies & Distributors | Small Cap Value
Company profile

India Globalization Capital, Inc. (IGC) is engaged in the development of cannabinoid-based therapies for indications such as Alzheimer's disease and pain. IGC operates through two segments: Life Sciences and Infrastructure. Life Sciences segment includes the development of potential new drugs, hand sanitizers and several hemp-based Cannabidiol (CBD) products and brands, wholesale of hemp extracts, including hemp crude extract and hemp isolate, white labeling of hemp-based products, and offering of tolling services like extraction and distillation to hemp farmers. Infrastructure segment includes construction contracts, rental of heavy construction equipment and purchase and resale of physical commodities used in infrastructure. IGC'S Life Sciences brands include Hyalolex, Holi Hemp, Holief, Herbo, and Sunday Seltzer. It is also focused on developing Naphthalene Monoimide (NMI) lead candidate, IGC-AD1, that targets neuropsychiatric symptoms associated with dementia in Alzheimer’s.

Day's Change
-0.0075 (-1.27%)
B/A Size
Day's High
Day's Low
(Heavy Day)

Today's volume of 19,306 shares is on pace to be much greater than IGC's 10-day average volume of 255,454 shares.




6 providers
August 08, 2022
IGC Reports Financial Results for the Quarter Ended June 30, 2022

India Globalization Capital, Inc. ("IGC" or the "Company") (NYSE American: IGC) announces its financial results for the three months ended June 30, 2022, which is the first quarter of the Company's 2023 fiscal year. (BusinessWire)

June 22, 2022
IGC Reports Financial Results for Fiscal Year Ended March 31, 2022

India Globalization Capital, Inc. ("IGC" or the "Company") (NYSE American: IGC) announces its financial results for Fiscal Year Ended March 31, 2022. Highlights for Fiscal 2022: IGC completed the first-in-human safety and tolerability trial on its...(BusinessWire)

June 21, 2022
IGC Acquires Exclusive Rights for a Potential Alzheimer's Drug Development Candidate

India Globalization Capital, Inc. (NYSE: IGC) is excited to announce that one of its subsidiaries reached an Intellectual Property (IP) license agreement for a potential Alzheimer's drug development candidate. (BusinessWire)

June 08, 2022
IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders

India Globalization Capital, Inc. (the "Company") (NYSE American: IGC) announced today that the United States Patent and Trademark Office ("USPTO") issued a patent (#11,351,152) to the Company titled "Method and Composition for Treating Seizure...(BusinessWire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.